Research suggests that Boswellia serrata (frankincense) may support gut health through anti-inflammatory, anti-tumor, and prebiotic-like mechanisms, though the available evidence is limited to preclinical and laboratory studies. An animal study found that a Boswellia serrata extract reduced colitis-associated colon tumor formation in mice, lowered key inflammatory proteins, and favorably shifted gut microbiota composition. A separate in vitro study using human fecal samples indicated that Boswellia, alongside other traditional herbs, altered gut bacterial communities in ways that may promote production of beneficial short-chain fatty acids such as butyrate and propionate, suggesting a possible prebiotic role. Both studies point in a supportive direction, but neither involved human clinical trials, so it remains unclear whether these findings translate to meaningful gut health benefits in people.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium ... | Other | 2017 | Supports | 72 |
| 16S rRNA gene profiling and genome reconstruction reveal community metabolic ... | Other | 2019 | Supports | 67 |